Aurinia Pharmaceuticals, Inc. (AUPH)
16.10
-0.01
(-0.06%)
USD |
NASDAQ |
Sep 11, 16:00
16.10
0.00 (0.00%)
After-Hours: 06:08
Aurinia Pharmaceuticals Price to Book Value : 3.480 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.480 |
| September 10, 2026 | 3.482 |
| September 09, 2026 | 3.512 |
| September 08, 2026 | 3.474 |
| September 04, 2026 | 3.476 |
| September 03, 2026 | 3.484 |
| September 02, 2026 | 3.521 |
| September 01, 2026 | 3.469 |
| August 31, 2026 | 3.482 |
| August 28, 2026 | 3.521 |
| August 27, 2026 | 3.561 |
| August 26, 2026 | 3.575 |
| August 25, 2026 | 3.621 |
| August 24, 2026 | 3.582 |
| August 21, 2026 | 3.599 |
| August 20, 2026 | 3.733 |
| August 19, 2026 | 3.495 |
| August 18, 2026 | 3.307 |
| August 17, 2026 | 3.305 |
| August 14, 2026 | 3.344 |
| August 13, 2026 | 3.281 |
| August 12, 2026 | 3.340 |
| August 11, 2026 | 3.322 |
| August 10, 2026 | 3.340 |
| August 07, 2026 | 3.426 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.487 |
| August 05, 2026 | 3.283 |
| August 04, 2026 | 3.227 |
| August 03, 2026 | 3.149 |
| July 31, 2026 | 3.216 |
| July 30, 2026 | 3.242 |
| July 29, 2026 | 3.281 |
| July 28, 2026 | 3.234 |
| July 27, 2026 | 3.290 |
| July 24, 2026 | 3.318 |
| July 23, 2026 | 3.294 |
| July 22, 2026 | 3.314 |
| July 21, 2026 | 3.381 |
| July 20, 2026 | 3.296 |
| July 17, 2026 | 3.450 |
| July 16, 2026 | 3.446 |
| July 15, 2026 | 3.480 |
| July 14, 2026 | 3.454 |
| July 13, 2026 | 3.465 |
| July 10, 2026 | 3.411 |
| July 09, 2026 | 3.586 |
| July 08, 2026 | 3.508 |
| July 07, 2026 | 3.506 |
| July 06, 2026 | 3.348 |
| July 02, 2026 | 3.374 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| enGene Therapeutics, Inc. | 0.5238 |
| Medicus Pharma Ltd. | -- |
| Xenon Pharmaceuticals, Inc. | 4.567 |
| Psyence Biomedical Ltd. | -- |
| Altimmune, Inc. | 1.341 |
Price to Book Value Related Metrics
| PE Ratio | 7.038 |
| PS Ratio | 7.046 |
| PEG Ratio | 0.0162 |
| Price to Free Cash Flow | 12.60 |
| Price | 16.10 |
| Earnings Yield | 14.21% |
| Market Cap | 2.140B |
| PEGY Ratio | 0.0162 |
| Operating PE Ratio | 15.61 |
| Normalized PE Ratio | 7.038 |